Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun:150-151:105131.
doi: 10.1016/j.jcv.2022.105131. Epub 2022 Mar 14.

SARS-CoV-2 transmitters have more than three times higher viral loads than non-transmitters - Practical use of viral load for disease control

Affiliations

SARS-CoV-2 transmitters have more than three times higher viral loads than non-transmitters - Practical use of viral load for disease control

R Jajou et al. J Clin Virol. 2022 Jun.

Abstract

Background: Quantitative results of SARS-CoV-2 testing reported as viral load copies/mL can provide valuable information, but are rarely used in practice. We analyze whether viral load in the upper respiratory tract is correlated with transmission and disease course and how this information can be used in practice.

Study design: Municipal Health Service (MHS) and clinical patients ≥18 years tested positive for SARS-CoV-2 with RT-PCR between June 1 and September 25, 2020 were included. Transmission was defined as an index having at least one contact tested positive. Test delay was defined as the time between symptom onset and SARS-CoV-2 testing.

Results: 683 patients were included (656 MHS and 27 clinical patients). The viral load was considerably lower among clinical patients compared to MHS patients: median log10 copies/mL 2.51 (IQR -1.52 - 6.46) vs 4.92 (IQR -0.54 - 8.26), p < 0.0001. However, the test delay was higher for clinical patients (median 7 [IQR 2 - 19] vs 3 [IQR 0 - 26] days, p < 0.0001). SARS-CoV-2 transmitters showed much higher viral loads than non-transmitters (log10 copies/mL 5.23 [IQR -0.52 - 8.26] vs 4.65 [IQR -0.72 - 8.00], p < 0.0001), but not for those with a test delay > 7 days. Higher viral loads were significantly correlated with older age and with more (severe) COVID-19 related symptoms.

Conclusion: Indexes that transmitted SARS-CoV-2 had more than three times higher viral loads than non-transmitters. Viral load information can be useful during source and contact tracing to prioritize indexes with highest risk of transmission, taking into account the test delay.

Keywords: COVID-19; SARS-CoV-2; Test delay; Transmission; Viral load.

PubMed Disclaimer

Conflict of interest statement

All authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Test delay and associated viral load (log10 copies/mL) for clinical and Municipal Health Service (MHS) patients.
Fig. 2
Fig. 2
Correlation between viral load (log10 copies/mL) and patient characteristics and disease course. MHS: Municipal Health Service. Bold values denote statistical significance at the p < 0.05 level.
Fig. 3
Fig. 3
Viral load (log10 copies/mL) of indexes that transmitted SARS-CoV-2 and indexes that did not among the total study population (A) and the clinical versus Municipal Health Service (MHS) patients (B). Bold values denote statistical significance at the p < 0.05 level.
Fig. 4
Fig. 4
Viral load (log10 copies/mL) of indexes that transmitted SARS-CoV-2 and indexes that did not, presented by test delay categories (0–3 days, 4–7 days, > 7 days). Bold values denote statistical significance at the p < 0.05 level.
Fig. 5
Fig. 5
Viral load (log10 copies/mL) by secondary attack rate and contact category.

Similar articles

Cited by

References

    1. Meyerowitz E.A., Richterman A., Gandhi R.T., Sax P.E. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Ann. Intern. Med. 2021;174:69–79. doi: 10.7326/M20-5008. https://doi.org/ - DOI - PMC - PubMed
    1. van Kampen J.J.A., van de Vijver D.A.M.C., Fraaij P.L.A., et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) Nat. Commun. 2021;12:267. doi: 10.1038/s41467-020-20568-4. https://doi.org/ - DOI - PMC - PubMed
    1. Bergmans B.J.M., Reusken C.B.E.M., van Oudheusden A.J.G., et al. Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort. Diagn. Microbiol. Infect. Dis. 2021 doi: 10.1016/j.diagmicrobio.2021.115392. - DOI - PMC - PubMed
    1. Walsh K.A., Jordan K., Clyne B., et al. SARS-CoV-2 detection, viral load and infectivity over the course of an infection. J. Infect. 2020;81:357–371. doi: 10.1016/j.jinf.2020.06.06701. https://doi.org/ - DOI - PMC - PubMed
    1. Zheng S., Fan J., Yu F., Feng B., et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020;369:m1443. doi: 10.1136/bmj.m1443. - DOI - PMC - PubMed